Page 82 - UCT2012 Health Sciences

Basic HTML Version

368
UCT RESEARCH REPORT 2012
variants associated with systemic atherosclerosis and
coronary atherosclerotic burden but not with venous
thromboembolism. Journal of the American College of
Cardiology, 60(8): 722-729.
Hendrik, S.H., Sudano, I., Theus, G., Noll, G. and
Burnier, M. 2012. Target blood pressure attainment with
antihypertensive therapy in Swiss primary care. Blood
Pressure, 21(4): 211-219.
Herrmann, C., Salas, P.F., Cawthray, J.F., De Kock, C., O
Patrick, B., Smith, P.J., Adam, M.J. and Orvig, C. 2012.
1,1’-Disubstituted ferrocenyl carbohydrate chloroquine
conjugates as potential antimalarials. Organometallics, 31:
5736-5747.
Herrmann, C., Salas, P.F., O Patrick, B., De Kock, C., Smith,
P.J., Adam, M.J. and Orvig, C. 2012. 1,2-Disubstituted
ferrocenyl carbohydrate chloroquine conjugates as
potential antimalarial agents. Dalton Transactions, 41:
6431-6442.
Herrmann, C., Salas, P.F., O Patrick, B., De Kock, C., Smith,
P.J., Adam, M.J. and Orvig, C. 2012. Modular synthesis
of 1,2- and 1,1’-disubstituted ferrocenyl carbohydrate
chloroquine and mefloquine conjugates as potential
antimalarial agents. Organometallics, 31: 5748-5759.
Holgate, S.L., Rabie, H., Smith, P. and Cotton, M. 2012.
Trough lopinavir concentrations in preterm HIV-infected
infants. Pediatric Infectious Disease Journal, 31(6): 602-604.
Howard, A., Gasana, M., Getahun, H., Harries, A.D., Lawn,
S.D., Miller, B., Nelson, L., Sitienei, J. and Coggin, W.L.
2012. PEPFAR support for the scaling up of collaborative
TB/HIV activities. Jaids-Journal of Acquired Immune
Deficiency Syndromes, 60(3): S136-S144.
Hu, D., Barajas-Martinez, H., Medeiros-Domingo, A., Crotti,
L., Veltmann, C., Schimpf, R., Urrutia, J., Alday, A., Casis,
O., Pfeiffer, R., Burashnikov, E., Caceres, G., Tester, D.J.,
Wolpert, C., Borggrefe, M., Schwartz, P.J., Ackerman, M.J.
and Antzelevitch, C. 2012. A novel rare variant in SCN1Bb
linked to Brugada syndrome and SIDS by combined
modulation of Nav1.5 and Kv4.3 channel currents. Heart
Rhythm, 9(5): 760-769.
Huisamen, B., Dietrich, D., Bezuidenhout, N., Lopes, J., Flepisi,
B., Blackhurst, D.M. and Lochner, A. 2012. Early cardiovascular
changes occuring in diet-induced, obese insulin-resistant rats.
Molecular and Cellular Biochemistry, 368: 37-45.
Isaacs, T. 2012. Skin hypersensitivity reactions to
preservatives. Current Allergy & Clinical Immunology,
25(1): 41-45.
Ishikawa, T., Sato, A., Marcou, C.A., Tester, D.J., Ackerman,
M.J., Crotti, L., Schwartz, P.J., On, Y.K., Park, J.E., Nakamura,
K., Hiraoka, M., Nakazawa, K., Sakurada, H., Arimura, T.,
Makita, N. and Kimura, A. 2012. A novel disease gene for
Brugada syndrome: sarcolemmal membrane-associated
protein gene mutations impair intracellular trafficking of
hNav1.5. Circulation-Arrhythmia and Electrophysiology, 5:
1098 -1107.
Jabar, A., Wallis, L.A., Ruter, A. and Smith, W.P. 2012.
Modified Delphi study to determine optimal data elements
for inclusion in an emergency management database
system. African Journal of Emergency Medicine (AfJEM),
2: 13-19.
Jackson, A., Nussbaum, J.C., Phulusa, J., Namarika, D.,
Chikasema, M., Kanyemba, C., Jarvis, J.N., Jaffar, S.,
Hosseinipour, M., van der Horst, C. and Harrison, T. 2012. A
phase II randomized controlled trial adding oral flucytosine
to high - dose fluconazole, with short-course amphotericin
B, for cryptococcal meningitis. Aids, 26: 1363-1370.
James, R.W., Frias, M.A. and Lecour, S. 2012. Lipid-
induced modulation of protective signalling pathways in
cardiovascular disease: the role of high density lipoproteins.
Current Signal Transduction Therapy, 7(2): 96-103.
Jarvis, J.N., Meintjes, G., Rebe, K., Williams, G.M., Bicanic,
T., Williams, A., Schutz, C., Bekker, L., Wood, R. and
Harrison, T. 2012. Adjunctive interferon- immunotherapy for
the treatment of HIV-associated cryptococcal meningitis: a
randomized controlled trial. Aids, 26: 1105-1113.
Jones, E., Owen, P. and Rayner, B.L. 2012. The association of
the R563Q genotype of the ENaC with phenotypic variation
in Southern Africa. American Journal of Hypertension,
25(12): 1286-1291.
Jones, P.W., Singh, D., Bateman, E.D., Agusti, A., Lamarca,
R., de Miquel, G., Segarra, R., Caracta, C. and Gil, E.G.
2012. Efficacy and safety of twice-daily aclidinium bromide
in COPD patients: the ATTAIN study. European Respiratory
Journal, 40(4): 830-836.
Karthikeyan, G., Zuhlke, L., Engel, M.E., Rangarajan, S.,
Yusuf, S., Teo, K. and Mayosi, B.M. 2012. Rationale and
design of a global rheumatic heart disease registry: the
remedy study. American Heart Journal, 163: 535-540.
Kaze, F.F., Ashuntantang, G., Kengne, A.P., Hassan, A., Halle,
M.P. and Muna, W. 2012. Acute hemodialysis complications
in end-stage renal disease patients: the burden and
implications for the under-resourced Sub-Saharan African
health systems. Hemodialysis International, 16: 526-531.